Systemic sclerosis (SSc) is a connective tissu e disorder characteri zed by fibrosis and vascular changes in th e skin and internal visceral or gans, with an autoimmune background. The increase of the c ollagen deposition is characteristic with SSc and depends on various cytokines. Am ong them, transforming growth factor-β (TGF-β) is considered to play a central role in the pathogenesis of SSc 1 .
TGF-β may be involved not only fibrosis but also in autoimmune response in Table 1 ). There were no significant di fferences in frequencies of visceral -3 -involvement including the esophagus, kidney, heart, and lung . Additionally, anti-topoisomerase I antibodies were positive in patients with norm al serum IL-17 at a significantly higher rate than those with elevated serum IL-17 (78% vs. 35%, p<0.05).
These results confirm that serum IL-17 levels are elevated in m ost SSc patients, suggesting that IL-17 is involved in a comm on pathway of SSc developm ent regardless of the diseas e subset. Our resu lts that elevated IL-17 levels correlated with lower TSS m ay indicate that IL-1 7 transiently increases in the earlier phase of the disease, which may be consistent with the report by Kurosawa et al. Furthermore, in our longitudinal analysis using serial sera, the tendency that serum IL-17 l evels attenuate during the follow-up period was observed (Fig. 1b) .
TGF-β is conventionally regarded as an anti-inflammatory cytokine, while it paradoxically plays a major role in SSc, which is considered as an autoimmune disease.
TGF-β alone induces T reg cells that inh ibit autoimmunity and prote ct against tissue injury 6 7 , but induces Th17 cells in the presence of IL-6 in mice. However, TGF-β may be dispensable in Th17 induction in human, where IL-1β has been demonstrated to play a dominant role in driving Th17 dif ferentiation 8 . Nonetheless, the curren t study possibly proposes a hypothesis that the dysregulated production of TGF-β and IL-6 may lead to the imbalance of Th17 vs. T reg in SSc. Furthermore, IL-17 induces IL-6 and IL-8 production and enhances the surface expression of intracellular adhesion molecule-1 in human fibroblasts 9 . Alternatively, since IL-17 induces the expression of matrix metalloproteases that f acilitate collagen metabolism 10 , augmented IL-17 production in SSc may serve as a protective factor against fibrotic process. Collectively, in addition to the recent identification of Th17 involvem ent in multip le sclerosis, rheumatoid arthritis, and inflammatory bowel diseases, Th17 cells may also be involved in the pathogenesis of SSc. 
